Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

145 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer (NSCLC) trial results

Completed

Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT00517790

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Site Reference ID/Investigator# 7194 Fountain Valley, California, United States
  • Site Reference ID/Investigator# 5617 Los Angeles, California, United States
  • Site Reference ID/Investigator# 7934 Sacramento, California, United States
  • Site Reference ID/Investigator# 5646 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

NCT06710132

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • University of California - Los Angeles - 300208353 Santa Monica, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
  • Georgetown University - Lombardi Comprehensive Cancer Center - 1134847 Washington D.C., District of Columbia, United States
  • D&H Cancer Research Center Margate, Florida, United States
View all 81 locations
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

NCT06305754

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kaiser Permanente - Oakland ( Site 0054) Oakland, California, United States
  • Kaiser Permanente - Roseville ( Site 0055) Roseville, California, United States
  • Kaiser Permanente - San Francisco ( Site 0056) San Francisco, California, United States
  • Kaiser Permanente - Santa Clara ( Site 0057) Santa Clara, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

NCT06074588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica ( Site 0023) Los Angeles, California, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0001) Jacksonville, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0005) Orange City, Florida, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003) Marietta, Georgia, United States
View all 194 locations
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

NCT05801029

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Hong Kong
  • Research Site Hong Kong
  • Research Site Hong Kong
  • Research Site Shatin, Hong Kong
View all 29 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details

Related conditions